Literature DB >> 28827010

Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy.

P Justin Rossi1, Sol De Jesus2, Christopher W Hess2, Daniel Martinez-Ramirez2, Kelly D Foote2, Aysegul Gunduz3, Michael S Okun2.   

Abstract

INTRODUCTION: Recent evidence suggests deep brain stimulation can alter impulse control. Our objective was to prospectively evaluate the effects of subthalamic nucleus (STN) and globus pallidus internus (GPi) deep brain stimulation on impulse control disorders (ICDs) in the setting of a conservative dopamine reduction strategy.
METHODS: Patients (n = 37) undergoing de novo, unilateral STN or GPi DBS lead implantation were evaluated pre-operatively and 6-12 months post-operatively for the presence of ICDs using the Questionnaire for Impulsivity in Parkinson's disease (QUIP) and by clinical interview.
RESULTS: Of the patients enrolled, 23 underwent electrode implantation in the globus pallidus internus and 14 were implanted in the subthalamic nucleus. Mean time to long term follow-up was 9.7 ± 2.4 months. Post-operative LEDD was not significantly lower than pre-operative LEDD (pre-op: 1238.53 ± 128.47 vs. post-op: 1178.18 ± 126.43, p = 0.2972, paired t-test). Mean QUIP scores were significantly lower at follow up compared to pre-operative baseline (1.51 ± 0.45 vs. 2.51 ± 0.58, p = 0.0447, paired t-test). Patients with ICDs pre-operatively (n = 14, 37.8%) had significant improvement in QUIP scores at follow-up (6.00 ± 0.94 vs. 2.64 ± 0.98, p = 0.0014, paired t-test). Improvement was not uniform across the cohort: 1 patient with ICD at baseline developed worsening symptoms, and 4 patients with no ICD pre-operatively developed clinically significant ICDs post-operatively.
CONCLUSION: When LEDD is relatively unchanged following STN or GPi DBS for PD, ICD symptoms tend toward improvement, although worsening and emergence of new ICDs can occur. In the setting of stable LEDD, these findings suggest that the intrinsic effects of DBS may play a significant role in altering impulsive behavior.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28827010      PMCID: PMC6837170          DOI: 10.1016/j.parkreldis.2017.08.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  32 in total

Review 1.  Deep brain stimulation: neuropsychological and neuropsychiatric issues.

Authors:  Valerie Voon; Cynthia Kubu; Paul Krack; Jean-Luc Houeto; Alexander I Tröster
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

2.  Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation.

Authors:  Tiphaine Rouaud; Sylvie Lardeux; Nicolas Panayotis; Dany Paleressompoulle; Martine Cador; Christelle Baunez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

3.  Characterizing motor and cognitive effects associated with deep brain stimulation in the GPi of hemi-Parkinsonian rats.

Authors:  Samantha R Summerson; Behnaam Aazhang; Caleb T Kemere
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2014-06-12       Impact factor: 3.802

4.  The effect of levodopa dose and body weight on dyskinesia in a prevalent population of people with Parkinson's disease.

Authors:  Richard W Walker; Anna R Howells; William K Gray
Journal:  Parkinsonism Relat Disord       Date:  2010-11-03       Impact factor: 4.891

Review 5.  Impulse control disorders in Parkinson's disease: recent advances.

Authors:  Valerie Voon; Arpan R Mehta; Mark Hallett
Journal:  Curr Opin Neurol       Date:  2011-08       Impact factor: 5.710

Review 6.  Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.

Authors:  Valerie Voon; Pierre-Olivier Fernagut; Jeff Wickens; Christelle Baunez; Manuel Rodriguez; Nancy Pavon; Jorge L Juncos; José A Obeso; Erwan Bezard
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

7.  Impulse control and related behaviors after bilateral subthalamic stimulation in patients with Parkinson's disease.

Authors:  Young Eun Kim; Hee Jin Kim; Han-Joon Kim; Jee-Young Lee; Ji Young Yun; Ji-Young Kim; Sun-Ha Paek; Beom S Jeon
Journal:  J Clin Neurosci       Date:  2013-05-24       Impact factor: 1.961

8.  Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.

Authors:  Alexandre Eusebio; Tatiana Witjas; Julien Cohen; Frédérique Fluchère; Elisabeth Jouve; Jean Régis; Jean-Philippe Azulay
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-02-27       Impact factor: 10.154

Review 9.  Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?

Authors:  Michael S Okun; Daniel Weintraub
Journal:  Mov Disord       Date:  2013-11-15       Impact factor: 10.338

10.  Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects.

Authors:  Polyvios Demetriades; Hugh Rickards; Andrea Eugenio Cavanna
Journal:  Parkinsons Dis       Date:  2011-02-20
View more
  8 in total

Review 1.  New pharmacological and neuromodulation approaches for impulsive-compulsive behaviors in Parkinson's disease.

Authors:  Giacomo Grassi; Giovanni Albani; Federica Terenzi; Lorenzo Razzolini; Silvia Ramat
Journal:  Neurol Sci       Date:  2021-04-14       Impact factor: 3.307

2.  Impulsivity Trait Profiles in Patients With Cerebellar Ataxia and Parkinson Disease.

Authors:  Tiffany X Chen; Chi-Ying R Lin; Megan A Aumann; Yan Yan; Nadia Amokrane; Natasha A Desai; Hakmook Kang; Daniel O Claassen; Sheng-Han Kuo
Journal:  Neurology       Date:  2022-04-15       Impact factor: 11.800

Review 3.  Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson's Disease.

Authors:  Robert S Eisinger; Adolfo Ramirez-Zamora; Samuel Carbunaru; Brandon Ptak; Zhongxing Peng-Chen; Michael S Okun; Aysegul Gunduz
Journal:  Front Neurol       Date:  2019-02-26       Impact factor: 4.003

4.  The Impact of Impulsivity on Quality of Life in Early Drug-Naïve Parkinson's Disease Patients.

Authors:  Dong-Woo Ryu; Joong-Seok Kim; Sang-Won Yoo; Yoon-Sang Oh; Kwang-Soo Lee
Journal:  J Mov Disord       Date:  2019-08-09

Review 5.  Impulse Control Disorders in Parkinson's Disease: From Bench to Bedside.

Authors:  Andrea Augustine; Catharine A Winstanley; Vaishnav Krishnan
Journal:  Front Neurosci       Date:  2021-03-12       Impact factor: 4.677

Review 6.  Subthalamic nucleus deep brain stimulation and impulsivity in Parkinson's disease: a descriptive review.

Authors:  Viviana Lo Buono; Marietta Lucà Trombetta; Rosanna Palmeri; Lilla Bonanno; Emanuele Cartella; Giuseppe Di Lorenzo; Placido Bramanti; Silvia Marino; Francesco Corallo
Journal:  Acta Neurol Belg       Date:  2021-05-07       Impact factor: 2.396

7.  Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease.

Authors:  Anna Sauerbier; Philipp Loehrer; Stefanie T Jost; Shania Heil; Jan N Petry-Schmelzer; Johanna Herberg; Pia Bachon; Salima Aloui; Alexandra Gronostay; Lisa Klingelhoefer; J Carlos Baldermann; Daniel Huys; Christopher Nimsky; Michael T Barbe; Gereon R Fink; Pablo Martinez-Martin; K Ray Chaudhuri; Veerle Visser-Vandewalle; Lars Timmermann; Daniel Weintraub; Haidar S Dafsari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-09-11       Impact factor: 10.154

8.  The effect on deep brain stimulation of subthalamic nucleus and dopaminergic treatment in Parkinson disease.

Authors:  Viviana Lo Buono; Rosanna Palmeri; Giuseppe Stroscio; Francesco Corallo; Giuseppe Di Lorenzo; Chiara Sorbera; Rosella Ciurleo; Vincenzo Cimino; Placido Bramanti; Silvia Marino; Lilla Bonanno
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.